Location History:
- Yokohama, JA (1976)
- Yokohama, JP (1982)
Company Filing History:
Years Active: 1976-1982
Title: Tsutomu Okada: Innovator in Fatty Acid Assaying and Antiviral Antibiotics
Introduction
Tsutomu Okada is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of biochemistry, particularly in the areas of fatty acid assaying and antiviral antibiotics. With a total of 2 patents, his work has implications for both medical and biochemical research.
Latest Patents
One of Okada's latest patents is a method for assaying fatty acids. This method involves using acyl-CoA synthetase in a system containing albumin and fatty acids. The assay is characterized by the presence of a water-soluble salt of a dibasic fatty acid with 10 to 18 carbon atoms or a benzenesulfonate that may have one or more C1-C5 side chains. Another significant patent is for 3-(5,7-Dimethyl-2-hydroxy-4-oxo-6,8-decadienyl)-glutarimide. This compound is prepared by cultivating Streptomyces pluricolorescens var. yamashitaensis (S-885) ATCC No. 21956 in an aqueous nutrient broth. The broth must contain a carbohydrate and a source of organic nitrogen until it achieves substantial antiviral activity. The antibiotic recovered from this culture broth is effective against viruses such as polio and A-type influenza.
Career Highlights
Tsutomu Okada is associated with Mitsubishi Chemical Industries Limited, where he has been able to apply his innovative ideas in a corporate setting. His work has not only advanced scientific understanding but has also contributed to practical applications in the industry.
Collaborations
Throughout his career, Okada has collaborated with notable colleagues such as Tadashi Hishida and Minoru Muramatsu. These collaborations have likely enriched his research and led to further advancements in his field.
Conclusion
Tsutomu Okada's contributions to the fields of fatty acid assaying and antiviral antibiotics highlight his innovative spirit and dedication to scientific advancement. His patents reflect a commitment to improving health outcomes through biochemistry.